M. Goto

Metronomic chemotherapy using oral cyclophosphamide and bevacizumab for recurrent cervical cancer: A multi-institutional retrospective study

H. Tsubamoto, T. Ueda, K. Inoue, 2022, Gynecologic oncology reports.

Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079).

M. Yokoyama, Y. Hirashima, M. Mikami, 2022, Gynecologic oncology.

Primary ependymoma of the ovary: a case report and literature review.

N. Yaegashi, K. Okamura, Y. Mikami, 2005, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601

A. Kawabata, H. Tsubamoto, K. Hori, 2022, Anti-cancer drugs.

Combination therapy of oral cyclophosphamide and bevacizumab for patients with recurrent ovarian and peritoneal cancer.

H. Tsubamoto, K. Hori, Kimihiko Ito, 2020, Medicine.

Hypovolaemic shock due to intra-abdominal haemorrhage from multiple uterine fibroids

K. Hori, Kimihiko Ito, E. Takaki, 2021, BMJ Case Reports.